|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of infectious diseases; Medicinal preparations for ... |
|
|
P/S
|
Medicinal preparations for the treatment and prevention of
cancer and infectious diseases; pharm... |
|
|
P/S
|
Medicinal preparations for the treatment and prevention of
cancer and infectious diseases; biolo... |
|
|
P/S
|
Medicinal preparations for the treatment and prevention of lymphopenia, cancer, and infectious di... |
|
|
P/S
|
Medicinal preparations for the treatment and prevention of
lymphopenia, cancer, and infectious d... |
|
|
P/S
|
Cells for scientific, laboratory or medical research; diagnostic preparations other than for medi... |
|
|
P/S
|
Cells for scientific, laboratory or medical research;
diagnostic preparations other than for med... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention of lymphopenia; pharmaceutical prepa... |
|
|
P/S
|
Pharmaceutical preparations for the treatment and prevention
of lymphopenia; pharmaceutical prep... |
|
|
Invention
|
Genetically modified nk-92 cell line.
This invention is directed to treatment of a subject havin... |
|
|
Invention
|
Neoepitope vaccine delivery vehicle and methods of making the same.
Disclosed herein are mannan ... |
|
|
Invention
|
Primary nk car constructs and methods.
Disclosed herein are recombinant nucleic acids, comprisin... |
|
|
Invention
|
Methods of treating bronchopulmonary dysplasia.
Provided herein are multi-chain chimeric polypep... |
|
|
Invention
|
Content authentication and validation via multi-factor digital tokens, systems, and methods.
Aut... |
|
|
Invention
|
Elimination of cd19-positive lymphoid malignancies by cd19-car expressing nk cells.
Provided her... |
|
|
Invention
|
Compositions and methods for producing il-16. An NK cell lysate is provided herein that includes ... |
|
|
Invention
|
Interleukin-15 superagonist n-803 in people experiencing long covid. Disclosed herein are methods... |
|
|
Invention
|
Interleukin-15 superagonist n-803 in people experiencing long covid.
Disclosed herein are method... |
|
|
Invention
|
Compositions and methods for nk-92 cells expressing native cd16.
A recombinant NK-92 cell has a ... |
|
|
Invention
|
Anti covid-19 therapies targeting nucleocapsid and spike proteins.
Disclosed herein are methods ... |
|
|
Invention
|
Distributed ledger for medicament administration tracking.
An autonomous tracking system receive... |
|
|
Invention
|
Adenoviral vector transduced apheresis product.
An immunotherapeutic composition is contemplated... |
|
|
Invention
|
System and method for administering a pharmaceutical composition with an intravenous tubing set. ... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptors.
Provided a... |
|
|
Invention
|
Tumoricidal and antimicrobial compositions and methods.
Provided herein are pharmaceutical compo... |
|
|
Invention
|
Combination therapies for multiple myeloma.
Compositions and methods are provided to treat and p... |
|
2024
|
Invention
|
Mononuclear cell derived nk cells.
Cord blood or peripheral blood NK cells are prepared from who... |
|
|
Invention
|
Systems and methods of analyzing assay images of virus strains using artificial intelligence.
Di... |
|
|
Invention
|
Systems and methods of analyzing assay images of virus strains using artificial intelligence. Dis... |
|
|
Invention
|
Advanced avatar dendritic cells.
Compositions, methods, and uses of recombinant immunoglobulin p... |
|
|
Invention
|
Anti-b7-h4 chimeric antigen receptor-modified nk-92 cells.
Recombinant NK cells, and particularl... |
|
|
Invention
|
Use of cd33car modified high affinity nk cells (t-hank) to reduce myeloid-derived suppressor cell... |
|
|
Invention
|
Virally educated t cells. Compositions and methods are described for a treatment of enduring vira... |
|
|
Invention
|
Virally educated t cells.
Compositions and methods are described for a treatment of enduring vir... |
|
|
Invention
|
Multi-chain chimeric polypeptides and uses thereof. Provided herein are multi-chain chimeric poly... |
|
|
Invention
|
Multi-chain chimeric polypeptides and uses thereof.
Provided herein are multi-chain chimeric pol... |
|
|
Invention
|
Multi-chain chimeric polypeptides and use thereof in the treatment of advanced solid tumors. Prov... |
|
|
Invention
|
Multi-chain chimeric polypeptides and use thereof in the treatment of advanced solid tumors.
Pro... |
|
|
Invention
|
Methods of generating, stimulating, or increasing proliferation of different subsets of cd8+ t ce... |
|
|
Invention
|
Methods and systems for producing a protein of interest in a plant.
Methods and systems for prod... |
|
|
Invention
|
Nant covid vaccine cross reactivity.
Recombinant SARS-CoV2 vaccine compositions and methods are ... |
|
|
Invention
|
Rig1 inhibition and therapeutic viral protein expression.
Viral transfection and expression of r... |
|
|
Invention
|
Rig1 inhibition and therapeutic viral protein expression. Viral transfection and expression of re... |
|
|
Invention
|
Methods of treating age-related and inflammatory diseases.
Provided herein are methods of treati... |
|
|
Invention
|
Lair-2 compositions and methods.
Provided herein are compositions and methods comprising Leukocy... |
|
|
Invention
|
Lair-2 and tnt-trap compositions and methods. Provided herein are compositions and methods compri... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells.
Provided are NK-92 cells expressing a chimeric a... |
|
|
Invention
|
Ex vivo generation of immune effector cells from apheresis material intermediates.
Methods and c... |
|
|
Invention
|
Ex vivo generation of immune effector cells from apheresis material intermediates. Methods and co... |
|
|
Invention
|
Methods of treating aging-related disorders.
Provided herein are methods of killing or reducing ... |
|
|
Invention
|
Single-chain chimeric polypeptides and uses thereof.
Provided herein are single-chain chimeric p... |
|
|
Invention
|
Distributed ledger for medicament administration tracking. An autonomous tracking system receives... |
|
|
Invention
|
Adenoviral vector transduced apheresis product. An immunotherapeutic composition is contemplated ... |
|
2023
|
Invention
|
Method of treating pancreatic cancer.
Provided herein are methods of treating unresectable advan... |
|
2022
|
Invention
|
Natural killer cells for chordoma therapy.
Provided herein are methods and compositions for trea... |
|
|
Invention
|
Generation of chimeric antigen receptor mrna molecules for expression in primary nk cells.
The i... |
